Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1988 1
1991 1
1992 1
1993 2
1995 1
1996 3
1997 4
1998 10
1999 15
2000 15
2001 15
2002 14
2003 7
2004 4
2005 1
2006 5
2007 8
2008 2
2009 4
2010 5
2011 2
2012 8
2013 5
2014 10
2015 17
2016 13
2017 24
2018 27
2019 40
2020 23
2021 34
2022 40
2023 49
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Jamshidi A, Liu MC, Klein EA, Venn O, Hubbell E, Beausang JF, Gross S, Melton C, Fields AP, Liu Q, Zhang N, Fung ET, Kurtzman KN, Amini H, Betts C, Civello D, Freese P, Calef R, Davydov K, Fayzullina S, Hou C, Jiang R, Jung B, Tang S, Demas V, Newman J, Sakarya O, Scott E, Shenoy A, Shojaee S, Steffen KK, Nicula V, Chien TC, Bagaria S, Hunkapiller N, Desai M, Dong Z, Richards DA, Yeatman TJ, Cohn AL, Thiel DD, Berry DA, Tummala MK, McIntyre K, Sekeres MA, Bryce A, Aravanis AM, Seiden MV, Swanton C. Jamshidi A, et al. Cancer Cell. 2022 Dec 12;40(12):1537-1549.e12. doi: 10.1016/j.ccell.2022.10.022. Epub 2022 Nov 17. Cancer Cell. 2022. PMID: 36400018 Free article.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L; DeLLphi-301 Investigators. Ahn MJ, et al. N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20. N Engl J Med. 2023. PMID: 37861218 Clinical Trial.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
Chertow GM, Pergola PE, Farag YMK, Agarwal R, Arnold S, Bako G, Block GA, Burke S, Castillo FP, Jardine AG, Khawaja Z, Koury MJ, Lewis EF, Lin T, Luo W, Maroni BJ, Matsushita K, McCullough PA, Parfrey PS, Roy-Chaudhury P, Sarnak MJ, Sharma A, Spinowitz B, Tseng C, Tumlin J, Vargo DL, Walters KA, Winkelmayer WC, Wittes J, Eckardt KU; PRO2TECT Study Group. Chertow GM, et al. N Engl J Med. 2021 Apr 29;384(17):1589-1600. doi: 10.1056/NEJMoa2035938. N Engl J Med. 2021. PMID: 33913637 Clinical Trial.
METHODS: In two phase 3, randomized, open-label, active-controlled, noninferiority trials, we compared vadadustat with the erythropoiesis-stimulating agent (ESA) darbepoetin alfa in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) not previously treate …
METHODS: In two phase 3, randomized, open-label, active-controlled, noninferiority trials, we compared vadadustat with the erythropoiesis-st …
Kaempferol: A Key Emphasis to Its Anticancer Potential.
Imran M, Salehi B, Sharifi-Rad J, Aslam Gondal T, Saeed F, Imran A, Shahbaz M, Tsouh Fokou PV, Umair Arshad M, Khan H, Guerreiro SG, Martins N, Estevinho LM. Imran M, et al. Molecules. 2019 Jun 19;24(12):2277. doi: 10.3390/molecules24122277. Molecules. 2019. PMID: 31248102 Free PMC article. Review.
Potentially modifiable determinants of malnutrition in older adults: A systematic review.
O'Keeffe M, Kelly M, O'Herlihy E, O'Toole PW, Kearney PM, Timmons S, O'Shea E, Stanton C, Hickson M, Rolland Y, Sulmont Rossé C, Issanchou S, Maitre I, Stelmach-Mardas M, Nagel G, Flechtner-Mors M, Wolters M, Hebestreit A, De Groot LCPGM, van de Rest O, Teh R, Peyron MA, Dardevet D, Papet I, Schindler K, Streicher M, Torbahn G, Kiesswetter E, Visser M, Volkert D, O'Connor EM; MaNuEL consortium. O'Keeffe M, et al. Clin Nutr. 2019 Dec;38(6):2477-2498. doi: 10.1016/j.clnu.2018.12.007. Epub 2018 Dec 11. Clin Nutr. 2019. PMID: 30685297 Free article.
Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, Lembo R, Gazivoda G, Likhvantsev VV, Lei C, Lozovskiy A, Di Tomasso N, Bukamal NAR, Silva FS, Bautin AE, Ma J, Crivellari M, Farag AMGA, Uvaliev NS, Carollo C, Pieri M, Kunstýř J, Wang CY, Belletti A, Hajjar LA, Grigoryev EV, Agrò FE, Riha H, El-Tahan MR, Scandroglio AM, Elnakera AM, Baiocchi M, Navalesi P, Shmyrev VA, Severi L, Hegazy MA, Crescenzi G, Ponomarev DN, Brazzi L, Arnoni R, Tarasov DG, Jovic M, Calabrò MG, Bove T, Bellomo R, Zangrillo A; MYRIAD Study Group. Landoni G, et al. N Engl J Med. 2019 Mar 28;380(13):1214-1225. doi: 10.1056/NEJMoa1816476. Epub 2019 Mar 19. N Engl J Med. 2019. PMID: 30888743 Free article. Clinical Trial.
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. Antonarakis ES, et al. N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3. N Engl J Med. 2014. PMID: 25184630 Free PMC article.
The Comet Interceptor Mission.
Jones GH, Snodgrass C, Tubiana C, Küppers M, Kawakita H, Lara LM, Agarwal J, André N, Attree N, Auster U, Bagnulo S, Bannister M, Beth A, Bowles N, Coates A, Colangeli L, Corral van Damme C, Da Deppo V, De Keyser J, Della Corte V, Edberg N, El-Maarry MR, Faggi S, Fulle M, Funase R, Galand M, Goetz C, Groussin O, Guilbert-Lepoutre A, Henri P, Kasahara S, Kereszturi A, Kidger M, Knight M, Kokotanekova R, Kolmasova I, Kossacki K, Kührt E, Kwon Y, La Forgia F, Levasseur-Regourd AC, Lippi M, Longobardo A, Marschall R, Morawski M, Muñoz O, Näsilä A, Nilsson H, Opitom C, Pajusalu M, Pommerol A, Prech L, Rando N, Ratti F, Rothkaehl H, Rotundi A, Rubin M, Sakatani N, Sánchez JP, Simon Wedlund C, Stankov A, Thomas N, Toth I, Villanueva G, Vincent JB, Volwerk M, Wurz P, Wielders A, Yoshioka K, Aleksiejuk K, Alvarez F, Amoros C, Aslam S, Atamaniuk B, Baran J, Barciński T, Beck T, Behnke T, Berglund M, Bertini I, Bieda M, Binczyk P, Busch MD, Cacovean A, Capria MT, Carr C, Castro Marín JM, Ceriotti M, Chioetto P, Chuchra-Konrad A, Cocola L, Colin F, Crews C, Cripps V, Cupido E, Dassatti A, Davidsson BJR, De Roche T, Deca J, Del Togno S, Dhooghe F, Donaldson Hanna K, Eriksson A, Fedorov A, Fern… See abstract for full author list ➔ Jones GH, et al. Space Sci Rev. 2024;220(1):9. doi: 10.1007/s11214-023-01035-0. Epub 2024 Jan 24. Space Sci Rev. 2024. PMID: 38282745 Free PMC article. Review.
Comet Interceptor will take advantage of the opportunity presented by ESA's F-Class call for fast, flexible, low-cost missions to which it was proposed. ...
Comet Interceptor will take advantage of the opportunity presented by ESA's F-Class call for fast, flexible, low-cost missions …
393 results